Prentice Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-300
Closed -$1K 177
2022
Q2
$1K Buy
+300
New +$1K ﹤0.01% 136
2021
Q4
Sell
-300
Closed -$2K 299
2021
Q3
$2K Sell
300
-150
-33% -$1K ﹤0.01% 302
2021
Q2
$3K Hold
450
﹤0.01% 288
2021
Q1
$3K Buy
+450
New +$3K ﹤0.01% 289